On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and ...
Hosted on MSN1mon
FedEx gets Loop Capital's upgrade on freight spin offLoop Capital sees the move as a key value driver, estimating a 32% upside for FedEx shares based on a sum-of-the-parts valuation. The parcel giant reported adjusted earnings per share of $4.05 for ...
CAN-2409 plus prodrug (valacyclovir) has been granted Fast Track Designation by the FDA for the treatment of PDAC, stage III/IV NSCLC in patients who are resistant to first line PD-(L)1 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback